35967 membres inscrits Accès abonné revues  Aide   Newsletter    Me connecter
Les Communiqués
 
 
     Nasdaq OMX
 
Rechercher dans le flux Nasdaq GlobeNewswire
Rechercher
Ossur Hf : Össur - Share options granted
Fri, 24 02 2017 13:50:58
Announcement from Össur hf. No. 15/2017 Reykjavík, 24 February 2017 Today, Össur hf. has granted 300,000 share options; 225,000 to Mr. Sveinn Sölvason, CFO and 75,000 to middle management. The (...)
Auris Medical Receives FDA Fast Track Designation for AM-111 in Acute Sensorineural Hearing Loss
Fri, 24 02 2017 13:00:00
Zug, Switzerland, Feb. 24, 2017 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in otolaryngology, today announced that the US Food and Drug (...)
Medtronic Receives CE Mark for Its Next Generation Cardiac Resynchronization Therapy-Pacemakers
Fri, 24 02 2017 13:00:00
Suite of Smart Heart Failure Devices Offers More-Effective Pacing, Expanded MRI Access DUBLIN - Feb. 24, 2017 - Medtronic plc (NYSE:MDT) today announced that it has received CE ( Conformité Européenne ) Mark for a (...)
Novartis receives positive CHMP opinion for Tafinlar® + Mekinist® in BRAF-positive non-small cell lung cancer (NSCLC) patients
Fri, 24 02 2017 12:07:03
If approved, Tafinlar + Mekinist will be the first targeted therapy specifically for NSCLC patients with a BRAF V600 mutation CHMP opinion based on positive data from pivotal study of patients with BRAF V600-positive (...)
Inivata: New Review of ctDNA Liquid Biopsies in Nature Reviews Cancer Co-Authored by Inivata CSO Nitzan Rosenfeld
Fri, 24 02 2017 12:00:00
  New Review of ctDNA Liquid Biopsies in Nature Reviews Cancer Co-Authored by Inivata CSO Nitzan Rosenfeld Research Triangle Park, NC and Cambridge, UK 24 February 2017 -- Inivata , a global (...)
Abeona Therapeutics annonce le rejet d'un recours collectif relatif aux valeurs mobilières
Fri, 24 02 2017 10:37:52
Le recours collectif relatif aux valeurs mobilières était dépourvu de toute base valide et a été volontairement abandonné NEW YORK et CLEVELAND, le 24 février 2017 (GLOBE NEWSWIRE) - Abeona Therapeutics Inc. (Nasdaq : ABEO), société (...)
Targovax ASA: Exercise of employee share options and restricted stock units in Targovax ASA
Fri, 24 02 2017 10:29:13
Reference is made to the stock exchange notice of 10 February 2017 regarding increase of the share capital in Targovax ASA (the "Company") relating to exercise of employee options and settlement of restricted stock units. As per 24 (...)
MPI - Communiqué from the EGM of MPI 24 February 2017
Fri, 24 02 2017 09:06:06
Today, February 24 th , 2017, Medical Prognosis Institute A/S held an Extraordinary Shareholders' Meeting to re-establish a previously granted warrant program. A summary of the resolutions follows below. All (...)
Notice for the Annual General Meeting of Novo Nordisk A/S
Fri, 24 02 2017 07:01:38
Bagsværd, Denmark, 24 February 2017 - The Annual General Meeting of Novo Nordisk A/S will be held on: Thursday 23 March 2017 at 2.00 pm (CET) at Bella Center, entrance West, Center Boulevard 5, 2300 Copenhagen S, Denmark. The (...)
Galapagos doses first healthy volunteer with CF combo GLPG2222 and GLPG2451
Thu, 23 02 2017 21:00:00
   Mechelen, Belgium; 23 February 2017 - Galapagos NV (Euronext & NASDAQ: GLPG) announces dosing of the first healthy volunteer with a combination of novel corrector GLPG2222 and novel potentiator GLPG2451 for cystic fibrosis in a Phase 1 (...)
Galapagos reports strong financial results and newsflow-rich pipeline
Thu, 23 02 2017 21:00:00
   Key 2016 results: Group revenues increased by ?91.0 million to ?151.6 million Operating loss reduced by ?77.9 million to ?11.5 million Net profit of ?54.0 million, compared (...)
New Solitaire(TM) Stent Retriever Study Validates Outcomes and Real-World Application of Stroke Treatment Best Practices
Thu, 23 02 2017 19:31:00
Economic Study Finds Solitaire Stent Retriever Highly Cost-Effective DUBLIN and HOUSTON - Feb. 23, 2017 - Data presented today on Medtronic's (NYSE:MDT) Solitaire stent retriever at the International Stroke Conference (...)
Abiomed Surpasses 50,000 Impella® Patients Treated in the United States
Thu, 23 02 2017 19:04:28
Milestone Highlights Significant Unmet Need for Treatment Options Among Advanced Heart Failure Patients DANVERS, Mass., Feb. 23, 2017 (GLOBE NEWSWIRE) --  Abiomed, Inc.  (NASDAQ:ABMD), a leading provider of breakthrough heart support (...)
Updated Phase 1 Data Show Bavarian Nordic's Vaccine Candidate Induces a Broad and Durable Immune Response against RSV
Thu, 23 02 2017 15:20:42
Antibody levels maintained against multiple targets 6 months post vaccination Additional T cell data confirms broad activity against all 5 RSV targets included in the vaccine COPENHAGEN, Denmark, February 23, 2017 (...)
Final Results from NICHE Phase III trial presented at the International Stroke Conference
Thu, 23 02 2017 14:30:00
Press release, Helsinki, 23 February 2017, at 4.30pm Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company"), a medical technology company with a pioneering navigated non-invasive brain stimulation system, (...)
Wolters Kluwer Update on Shares Held in Treasury
Thu, 23 02 2017 13:30:00
Wolters Kluwer Update on Shares Held in Treasury February 23, 2017 - Wolters Kluwer announces that, following the release of 1.4 million ordinary shares under the Long-Term Incentive Plan (LTIP) 2014-16, the number of (...)
Abeona Therapeutics Announces Dismissal of Securities Class Action Lawsuit
Thu, 23 02 2017 12:43:00
Securities Class Action Lawsuit lacked any valid basis and was voluntarily dismissed NEW YORK and CLEVELAND, Feb. 23, 2017 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq:ABEO),  a leading clinical-stage biopharmaceutical company (...)
EDAP Announces Preliminary Unaudited Full Year 2016 Revenue
Thu, 23 02 2017 12:30:00
EDAP Announces Preliminary Unaudited Full Year 2016 Revenue Full year 2016 revenue increased to approximately ?35.6 million  2016 HIFU revenues recorded over 63% growth Strong cash position of ?22 million Company to (...)
Summit Therapeutics plc : Exercise of Warrants
Thu, 23 02 2017 12:15:00
Summit Therapeutics plc ("Summit" or the "Company") EXERCISE OF WARRANTS Oxford, UK, 23 February 2017 - Summit Therapeutics plc (AIM: SUMM, NASDAQ: SMMT), the drug discovery and development company (...)
RedHill Biopharma Reports 2016 Fourth Quarter and Full-Year Financial Results
Thu, 23 02 2017 12:13:25
RedHill maintains a strong and debt-free balance sheet with approximately $66 million in cash and cash equivalents at the end of 2016, allowing the Company to continue to execute its development   and U.S. commercialization plans (...)
William Demant Holding A/S: Management changes in William Demant
Thu, 23 02 2017 07:08:51
Company announcement no 2017-02 23 February 2017 Management change in William Demant Holding A/S Søren Nielsen new President & CEO Niels B. Christiansen new Chairman of the Board President (...)
Acarix presents Year-end Report, January - December 2016
Thu, 23 02 2017 07:00:00
Year-end Report, January - December 2016 Completed listing prepares Acarix for commercialization of CADScor®System "Heart disease is the number one killer worldwide and Coronary Artery Disease (CAD) affects more than 120 million people (...)
Ossur Hf : AGM 9 March 2017 - Final agenda and proposals
Thu, 23 02 2017 07:00:00
Announcement from Ossur hf. no:14/2017 Reykjavik, 23 February 2017 Enclosed is the final agenda and proposals for Össur's Annual General Meeting, to be held on Thursday 9 March 2017. The meeting will be held at Össur's headquarters (...)
Financière de Tubize SA: Rapport financier annuel 2016
Thu, 23 02 2017 07:00:00
Communiqué de presse 23 février 2017 - 8:00h CET   FINANCIERE DE TUBIZE SA Allée de la Recherche 60, 1070 Bruxelles Contact: Marc Van Steenvoort, directeur, marc.van.steenvoort@gmail.com Rapport financier (...)
Financière de Tubize SA: 2016 annual financial report
Thu, 23 02 2017 07:00:00
Press release 23 February 2017 - 8:00h CET   FINANCIERE DE TUBIZE SA/NV Allée de la Recherche 60, 1070 Brussels Contact: Marc Van Steenvoort, directeur, marc.van.steenvoort@gmail.com Annual financial report (...)
publicités
publicité
 
  KauriWeb

Afficher toutes les thématiques